You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

combined chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Contrast Enhanced Ultrasound Trial in Hershey (Lumason)

Not yet recruiting
  • Breast Cancer
  • Contrast Enhanced Ultrasound
  • Hershey, Pennsylvania
    Penn State Health College of Medicine
Jul 19, 2023

NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Crizotinib - Usual
  • Crizotinib - Study
  • Rockville, Maryland
    Medicine Invention Design, Inc. - IORG0007849
Oct 5, 2023

Oral Squamous Cell Carcinoma Trial (Tislelizumab, Albumin paclitaxel, Cisplatin)

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • (no location specified)
May 7, 2023

Advanced Colorectal Cancer Trial in Hangzhou (Fruquintinib Combined With Chemotherapy)

Not yet recruiting
  • Advanced Colorectal Cancer
  • Fruquintinib Combined With Chemotherapy
  • Hangzhou, Zhejing, China
    Zhejiang Cancer Institute & Hospital
Jun 29, 2023

Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)

Recruiting
  • Extensive Small Cell Lung Cancer
  • Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
  • Jinan, Shan Dong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Nov 6, 2023

Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)

Recruiting
  • Gastric Cancer
  • Taurine
  • +4 more
  • Xi'an, Shaanxi, China
    Tang-Du Hospital
Nov 2, 2023

Breast Cancer Trial in Xining (Sintilimab+Apatinib+Albumin-Bound Paclitaxel(Nab-Paclitaxel)+Carboplatin)

Recruiting
  • Breast Cancer
  • Sintilimab+Apatinib+Albumin-Bound Paclitaxel(Nab-Paclitaxel)+Carboplatin
  • Xining, Qinghai, China
    Affiliated Hospital of Qinghai University
Apr 21, 2022

Advanced Mucosal Melanoma Trial (Envafolimab combined with recombinant human endostatin and first-line chemo)

Not yet recruiting
  • Advanced Mucosal Melanoma
  • Envafolimab combined with recombinant human endostatin and first-line chemotherapy
  • (no location specified)
Sep 15, 2023

Osteosarcoma Trial (Surufatinib plus chemo, Chemotherapy)

Not yet recruiting
  • Osteosarcoma
  • (no location specified)
Jun 29, 2023

Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • without concurrent cisplatin chemotherapy
  • with concurrent cisplatin chemotherapy
  • Fuzhou, Fujian, China
    Department of radiation oncology, Fujian cancer hospital
Oct 18, 2023

Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

Not yet recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • (no location specified)
Jun 11, 2023

Gastric Cancer Trial in Xi'an (Penpulimab combined with Anlotinib Hydrochloride Capsules and chemo;Cadonilimab combined with

Not yet recruiting
  • Gastric Cancer
  • Penpulimab combined with Anlotinib Hydrochloride Capsules and chemotherapy;Cadonilimab combined with Anlotinib Hydrochloride Capsules and chemotherapy
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of Air Force Military Medical Univ
Mar 23, 2023

Uterine Cervical Tumors, Chemoradiotherapy, Adjuvant Chemo Trial in Liuzhou (paclitaxel combined with platinum)

Recruiting
  • Uterine Cervical Neoplasms
  • +2 more
  • paclitaxel combined with platinum
  • Liuzhou, Guangxi, China
    the Fourth Affiliated Hospital of Guangxi Medical University
Feb 16, 2023

Tislelizumab Combined With Chemotherapy in First-line Treatment

Active, not recruiting
  • Tislelizumab
  • +3 more
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 6, 2023

Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)

Not yet recruiting
  • Pediatric Cancer
  • +2 more
  • Arsenic trioxide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 12, 2023

Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)

Recruiting
  • Gastric Cancer
  • sintilimab+metronomic PLOF
  • Shanghai, China
    Huashan Hospital, Fudan University
Sep 22, 2023

Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)

Recruiting
  • Gastric Cancer
  • Taurine
  • +3 more
  • Xi'an, Shaanxi, China
    Tang-Du Hospital
Nov 7, 2023

Advanced Lung Squamous Cell Carcinoma Trial in Chengdu (low-dose radiation therapy and stereotactic body radiation therapy,

Not yet recruiting
  • Advanced Lung Squamous Cell Carcinoma
  • low-dose radiation therapy and stereotactic body radiation therapy
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Nov 13, 2023

Pancreatic Ductal Adenocarcinoma Trial (Thermal Ablation, Chemotherapy)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • (no location specified)
Nov 9, 2022

Nausea With Vomiting Chemo-Induced Trial in Wuhan (Ondansetron every 3 weeks, Aprepitant, Dexamethasone)

Not yet recruiting
  • Nausea With Vomiting Chemotherapy-Induced
  • Ondansetron every 3 weeks
  • +3 more
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Oct 8, 2023

Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

Recruiting
  • Untreated Advanced Non-small Cell Lung Cancer
  • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Nov 13, 2023

NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Tirelizumab；Chemotherapy monotherapy
  • (no location specified)
Jul 27, 2023

Esophageal Squamous Cell Carcinoma Trial in Hangzhou (Cadonilimab combined Anlotinib)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Cadonilimab combined Anlotinib
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 6, 2023

Glioblastoma Trial in Berlin (Radiofrequency electromagnetic field treatment)

Recruiting
  • Glioblastoma
  • Radiofrequency electromagnetic field treatment
  • Berlin, Germany
    Charité Universitätsmedizin Berlin
Nov 15, 2023

Sintilimab and Anlotinib in Combination With Chemo Trial in Xi'an (Sintilimab and anlotinib in combination with chemo)

Completed
  • Sintilimab and Anlotinib in Combination With Chemotherapy
  • Sintilimab and anlotinib in combination with chemotherapy
  • Xi'an, Shanxi, China
  • +1 more
Aug 27, 2023